# NEXIEN BIOPHARMA, INC.

NEXIEN BIOPHARMA, INC. is a company headquartered in Glendale, CO, United States.

## Company overview

- **Legal name:** NEXIEN BIOPHARMA, INC.
- **Former names in filing history:** Intiva BioPharma Inc. (2017-11-29 to 2018-09-12); Kinder Holding Corp. (2014-11-14 to 2017-11-06)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Glendale, CO, United States
- **Incorporated in:** DE
- **Fiscal year end:** June 30
- **SEC CIK:** 0001625288

## About

NEXIEN BIOPHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001625288, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-10-22, it reported net income of USD -239,113; total assets of USD 4,183 for the fiscal period ended 2024-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-06-30)

- **Net income:** -$239,113 (USD -239,113)
- **Total assets:** $4,183 (USD 4,183)
- **Cash and equivalents:** $4,183 (USD 4,183)
- **Operating cash flow:** -$64,364 (USD -64,364)

### FY2023 (period ended 2023-06-30)

- **Net income:** -$361,902 (USD -361,902)
- **Total assets:** $43,127 (USD 43,127)
- **Cash and equivalents:** $35,147 (USD 35,147)
- **Operating cash flow:** -$81,751 (USD -81,751)

### FY2022 (period ended 2022-06-30)

- **Net income:** -$626,357 (USD -626,357)
- **Total assets:** $124,518 (USD 124,518)
- **Operating cash flow:** -$75,143 (USD -75,143)

### FY2021 (period ended 2021-06-30)

- **Net income:** -$1.9M (USD -1,859,942)
- **Total assets:** $25,541 (USD 25,541)
- **Cash and equivalents:** $18,041 (USD 18,041)
- **Operating cash flow:** -$90,745 (USD -90,745)

## Recent SEC filings

- Form 10-Q — filed 2025-05-14 — period 2025-03-31 — 10-Q
- Form 10-Q — filed 2025-02-14 — period 2024-12-31
- Form 10-Q — filed 2024-11-18 — period 2024-09-30
- Form 10-K — filed 2024-10-22 — period 2024-06-30
- Form 10-Q — filed 2024-05-15 — period 2024-03-31
- Form 10-Q — filed 2024-02-20 — period 2023-12-31
- Form 10-Q — filed 2023-11-14 — period 2023-09-30
- Form 10-K — filed 2023-09-28 — period 2023-06-30
- Form 10-Q — filed 2023-05-17 — period 2023-03-31
- Form 10-Q — filed 2023-02-08 — period 2022-12-31
- Form 10-Q — filed 2022-11-09 — period 2022-09-30
- Form 10-K — filed 2022-09-28 — period 2022-06-30

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/nexien-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology